CNKSR3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.269600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.863400E-01
Normal-vs-Stage2
1.139160E-01
Normal-vs-Stage3
6.161000E-01
Normal-vs-Stage4
2.664000E-01
Stage1-vs-Stage2
6.755400E-01
Stage1-vs-Stage3
9.992200E-01
Stage1-vs-Stage4
7.758000E-01
Stage2-vs-Stage3
8.885800E-01
Stage2-vs-Stage4
9.829400E-01
Stage3-vs-Stage4
8.874600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.421370E-01
Normal-vs-AfricanAmerican
2.501600E-01
Normal-vs-Asian
5.536100E-02
Caucasian-vs-AfricanAmerican
8.054600E-01
Caucasian-vs-Asian
2.480600E-01
AfricanAmerican-vs-Asian
3.126600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.140030E-01
Normal-vs-Female
1.583560E-01
Male-vs-Female
9.485400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.873000E-01
Normal-vs-Age(41-60Yrs)
4.106400E-01
Normal-vs-Age(61-80Yrs)
6.111900E-02
Normal-vs-Age(81-100Yrs)
2.464100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.859400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.519000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.164100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.420300E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.779700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.991000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.602030E-01
Normal-vs-Daily Drinker
3.171600E-02
Normal-vs-Weekly Drinker
1.474440E-01
Normal-vs-Occasional Drinker
7.663600E-02
Normal-vs-Social Drinker
6.181200E-01
Non Drinker-vs-Daily Drinker
2.479600E-01
Non Drinker-vs-Weekly Drinker
6.206600E-01
Non Drinker-vs-Occasional Drinker
6.717800E-01
Non Drinker-vs-Social Drinker
4.511200E-01
Daily Drinker-vs-Weekly Drinker
6.636200E-01
Daily Drinker-vs-Occasional Drinker
4.857200E-01
Daily Drinker-vs-Social Drinker
1.669180E-01
Weekly Drinker-vs-Occasional Drinker
8.930000E-01
Weekly Drinker-vs-Social Drinker
3.253000E-01
Occasional Drinker-vs-Social Drinker
3.219400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.821700E-02
Normal-vs-Grade 2
6.756100E-02
Normal-vs-Grade 3
4.718300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.045600E-01
Grade 1-vs-Grade 3
8.874000E-02
Grade 1-vs-Grade 4
2.821700E-02
Grade 2-vs-Grade 3
3.292800E-01
Grade 2-vs-Grade 4
6.756100E-02
Grade 3-vs-Grade 4
4.718300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.721630E-01
Normal-vs-NonDiabetic
1.232400E-01
Diabetic-vs-NonDiabetic
5.300800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.911400E-01
Normal-vs-NoPancreatitis
6.975900E-02
Pancreatitis-vs-NoPancreatitis
2.706600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.123970E-01
Normal-vs-N1
1.317980E-01
N0-vs-N1
7.449800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.827700E-02
Normal-vs-TP53-NonMutant
1.054570E-01
TP53-Mutant-vs-TP53-NonMutant
7.348100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
